pharmaphorum September 18, 2024
A pharmacy benefit manager has thrown a legal punch at the Federal Trade Commission (FTC), taking issue with the agency’s recent report accusing PBMs of using anti-competitive practices to drive up prescription drug prices.
The complaint, filed by Express Scripts owner Cigna against the FTC and Commissioner Lina Khan, is seeking the retraction of the report, which the company claims is “unfair, biased, erroneous, and defamatory” against the PBM industry and is “seventy-four pages of unsupported innuendo.”
The suit claims that the agency ignored the evidence provided by Express Scripts and other PBMs, demonstrates “clear ideological bias”, and is advancing a “false and damaging narrative” that could drive up drug prices even further. Express Scripts also wants Khan to be...
Today's Sponsors
Today's Sponsor